Charles Struzynski

Statistics

Publications

Citations

112

H-Index

Active since

2003

Affiliations

Bristol-Myers Squibb (United States)(Current)

Charles Struzynski is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, molecular pharmacology, and pharmacology.

Publications per year

2003–2011

Publications

Microwave-assisted synthesis of primary amine HX salts from halides and 7 M ammonia in methanol

Mark G. Saulnier, Kurt Zimmermann, Charles Struzynski et al. · Tetrahedron Letters · 2003 · 26 citations

Natural Sciences, Chemical Engineering, Chemistry +8

2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924

Mark G. Saulnier, David B. Frennesson, Mark D. Wittman et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors

Kurt Zimmermann, Mark D. Wittman, Mark G. Saulnier et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1

I. B. Gurevich, Carmen Zhang, Priscilla C. Encarnacao et al. · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2011 · 21 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Pyrrolotriazine-5-carboxylate ester inhibitors of EGFR and HER2 protein tyrosine kinases and a novel one-pot synthesis of C-4 subsitituted pyrrole-2,3-dicarboxylate diesters

Harold Mastalerz, Ashvinikumar V. Gavai, Brian E. Fink et al. · Canadian Journal of Chemistry · 2006 · 14 citations

Medicine, Medicinal Chemistry, Pharmacology +13

1–5 of 5